Abstract:Post-translational modifications (PTMs) on tau have long been recognized as affecting protein function and contributing to neurodegeneration. The explosion of information on potential and observed PTMs on tau provides an opportunity to better understand these modifications in the context of tau homeostasis, which becomes perturbed with aging and disease. Prevailing views regard tau as a protein that undergoes abnormal phosphorylation prior to its accumulation into the toxic aggregates implicated in Alzheimer's disease (AD) and other tauopathies. However, the phosphorylation of tau may, in fact, represent part of the normal but interrupted function and catabolism of the protein. In addition to phosphorylation, tau undergoes another forms of post-translational modification including (but not limited to), acetylation, ubiquitination, glycation, glycosylation, SUMOylation, methylation, oxidation, and nitration. A holistic appreciation of how these PTMs regulate tau during health and are potentially hijacked in disease remains elusive. Recent studies have reinforced the idea that PTMs play a critical role in tau localization, protein-protein interactions, maintenance of levels, and modifying aggregate structure. These studies also provide tantalizing clues into the possibility that neurons actively choose how tau is post-translationally modified, in potentially competitive and combinatorial ways, to achieve broad, cellular programs commensurate with the distinctive environmental conditions found during development, aging, stress, and disease. Here, we review tau PTMs and describe what is currently known about their functional impacts. In addition, we classify these PTMs from the perspectives of protein localization, electrostatics, and stability, which all contribute to normal tau function and homeostasis. Finally, we assess the potential impact of tau PTMs on tau solubility and aggregation. Tau occupies an undoubtedly important position in the biology of neurodegenerative diseases. This review aims to provide an integrated perspective of how post-translational modifications actively, purposefully, and dynamically remodel tau function, clearance, and aggregation. In doing so, we hope to enable a more comprehensive understanding of tau PTMs that will positively impact future studies.

Proteasomal Degradation of the Intrinsically Disordered Protein Tau at Single-Residue Resolution.

Defects in the autophagy lysosomal pathway in a cell model of disease‐associated tau

Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression

Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease

Phosphorylation of tau at a single residue inhibits binding to the E3 ubiquitin ligase, CHIP

Structural Insight into Tau Protein'S Paradox of Intrinsically Disordered Behavior, Self-Acetylation Activity, and Aggregation

Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates

Differential compartmental processing and phosphorylation of pathogenic human tau and native mouse tau in the line 66 model of frontotemporal dementia

A non-autonomous protein quality control mechanism targeting tau aggregate propagation

Hiding in plain sight: Complex interaction patterns between Tau and 14-3-3ζ protein variants

Tau protein structure and dynamics

Dephosphorylation Passivates the Seeding Activity of Oligomeric Tau Derived From Alzheimer’s Brain

Alzheimer’s Disease and Tau Self-Assembly: In the Search of the Missing Link

Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers

Crosstalk between tau protein autoproteolysis and amyloid fibril formation

Interaction of full-length Tau with negatively charged lipid membranes leads to polymorphic aggregates

Phosphorylation of Trans‐active Response DNA‐binding Protein‐of 43 Kda Promotes Its Cytoplasmic Aggregation and Modulates Its Function in Tau Mrna Stability and Exon 10 Alternative Splicing

Paired Helical Filament-Forming Region of Tau (297-391) Influences Endogenous Tau Protein and Accumulates in Acidic Compartments in Human Neuronal Cells

Ubiquitin is Associated with Early Truncation of Tau Protein at Aspartic Acid421 during the Maturation of Neurofibrillary Tangles in Alzheimer's Disease

Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation